Sciensus
Sciensus is a life sciences business specializing in patient access, engagement, and insight solutions. Sitting at the intersection of patients and medicine, the company leverages its 70 million patient interactions to uncover data and insights, enabling the deployment of innovative healthcare solutions for patients with long-term conditions, rare diseases, and cancer.
With a 30-year track record of supporting patients across the UK, Switzerland, and Europe, Sciensus combines its clinical experience with the latest technology to assist over 200,000 patients annually in optimizing their medication usage. The company's profound patient insight enables it to understand and address the challenges faced by patients, carers, and families.
As the healthcare landscape evolves, Sciensus leads the way by recognizing the necessity of aligning emerging technologies with profound patient insight. The company's approach revolves around providing practical, emotional, and clinical support to patients, equipping them to reach their goals, achieve better outcomes, and continue with their lives.
Founded in 2003 and headquartered in the United Kingdom, Sciensus is poised to capitalize on the evolving healthcare industry through its focus on patient-centric solutions and technology integration.There is no investment information
No recent news or press coverage available for Sciensus.